Cell Based Assays Drugs Small Molecule 
Broad Institute
JUNE 30, 2023
The researchers also looked at the tool’s ability to detect changes in cellular phenotypes after exposure to drugs and small molecule compounds. Typically, studying drug therapies is an expensive and time-consuming undertaking.
PerkinElmer
JANUARY 7, 2020
Drug discovery is always evolving. From new processes to advanced technologies, excellence in drug discovery is the result of combining different approaches. Emerging and Resurrecting Technologies We’ve made huge strides in the drug discovery process, and it’s only getting better as we move forward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PerkinElmer
SEPTEMBER 8, 2019
Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe. Learn more about Cisbio here.
Molecular Design
DECEMBER 31, 2023
BW2014 has been heavily cited in the drug discovery literature (it was cited as the first reference in the ACS assay interference editorial which I reviewed in K2017 ) despite providing nothing in the way of practical advice for dealing with nuisance behavior. Given that M2003 had been published over a decade previously.
Molecular Design
DECEMBER 19, 2023
Covalent bond formation between ligands and targets is a drug design tactic for exploiting molecular recognition elements in targets that are difficult to make beneficial contacts with. This Perspective is intended to jumpstart this important scientific discussion. Subscripting doesn't work well in blogger and so I'll use K.i
Broad Institute
JUNE 21, 2023
The researchers also looked at the tool’s ability to detect changes in cell morphology after exposure to drugs and small molecule compounds. Typically, studying drug therapies is an expensive and time-consuming undertaking.
Molecular Design
JUNE 8, 2023
I’ll start the review of L2021 with annotation of the abstract: "Physicochemical descriptors commonly used to define ‘drug-likeness’ and ligand efficiency measures are assessed for their ability to differentiate marketed drugs from compounds reported to bind to their efficacious target or targets. [I
Expert insights. Personalized for you.
Let's personalize your content